Klinikum Nürnberg

Conditional progression-free survival in patients with metastatic hormone receptor-positive, human epidermal growth factor receptor 2-negative breast cancer treated with first-line ribociclib and endocrine therapy: real-world data from the RIBANNA study (2025) Decker T, Brucker C, Engel A, Fasching P, Göhler T, Jackisch C, Janssen J, et al. Journal article Frailty and prehospital emergency care: implications for paramedic education (2025) Krohn JN, Singler K Journal article Correction: The sarcoma ring trial: a case-based analysis of inter-center agreement across 21 German-speaking sarcoma centers (Journal of Cancer Research and Clinical Oncology, (2025), 151, 1, (30), 10.1007/s00432-024-06063-z) (2025) Roohani S, Handtke J, Hummedah K, Albertsmeier M, Andreou D, Apostolidis L, Augustin M, et al. Journal article, Erratum Real-World-Evidence of Digital Health Applications (DiGAs) in Rheumatology: Insights from the DiGAReal Registry (2025) Albrecht A, Taubmann J, Minopoulou I, Hatscher L, Kleinert S, Mühlensiepen F, Welcker M, et al. Journal article Using Boomwhackers in geriatrics: A pilot study on well-being in patients with mental health problems including dementia (2025) Wunner C, Betzold J, Stemmler M, Gosch M, Singler K Journal article Dedifferentiated and Undifferentiated Melanoma (2025) Iro AK, Agaimy A Journal article, Review article Digital health applications: A new approach in the management of comobidities Digitale Gesundheitsanwendungen: Ein neuer Ansatz im Management von Komorbiditäten (2025) Bartsch V, Knitza J Journal article, Review article Disease risk but not remission status determines transplant outcomes in AML: long-term outcomes of the ASAP trial (2025) Stelljes M, Middeke JM, Bug G, Wagner-Drouet EM, Müller LP, Schmid C, Krause S, et al. Journal article Needs, distress, state-of-health and quality-of-life in survivors of stage III melanoma: Results from the cross-sectional MESSAGE study (2025) Skoda EM, Jansen C, Peltz L, Schweda A, Teufel M, Livingstone E, Zimmer L, et al. Journal article Current practice of pathologic response assessment following chemoimmunotherapy for non-small cell lung cancer (NSCLC) in Germany: first real-world data from the multicentre Re-GraDE study (2025) Elsner F, Kümpers C, Ott G, Döring J, Schildknecht K, Fisseler-Eckhoff A, von Laffert M, et al. Journal article